The Valley Desk

NCT03546582 · Interventional trial

SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Overall registry status Active not recruiting

Phase 2

Conditions Head and Neck Squamous Cell Carcinoma (HNSCC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov